The spread of the corona virus began in December 2019 in one of the Chinese seafood markets, and since then, we have witnessed the mutation of this deadly virus and the spread of new species. According to figures released by the World Health Organization, more than 1.6 million people died of coronary artery disease last year, and more than 76 million people worldwide were infected. In recent days, a new name has come to the fore: the Omicron virus, which is a new strain of the corona virus, announces a new leap in its structure. In this article, we will tell you what the Amicron virus is, and we will provide you with the latest information about it, citing world-renowned articles. Stay with us.
When was the first case of Amicron corona detected?
The first case of Amicron corona, also known as B.1.1.529 (B.1.1.529), was first identified on Tuesday, November 23rd. The numerous mutations that have occurred in the structure of this new strain of coronavirus over the past few days have caused great concern to scientists and researchers, mutations that can weaken the body’s immune system.
This new corona strain has also been identified as the main cause of the rising number of cases in the South African province of Gauteng over the past two weeks.
These two factors have led the UK’s senior medical adviser to consider the Amicron corona “the most worrying strain of the virus” to date.
Where did the spread of the new strain begin?
According to the first information and news published, the first case of Amicron virus was considered to be a citizen of South Africa, but researchers believe that this case does not necessarily prove that a new strain has started in this region. The first tests and samples that showed the mutation of the virus were performed on November 11 and related to the disease in Botswana (one of the neighboring countries of South Africa).
Cases of Amicron corona have already been identified in these countries:
- Hong Kong.
According to reports, the new virus has not yet reached the United States.
What are the signs and symptoms of Amicron Corona?
In an interview with the BBC on Sunday, Dr Angelique Coetzee, a senior official at the South African Medical Association, said she had examined patients on November 18 for “abnormal symptoms”. Symptoms that were slightly different from those of the other side of the corona virus, delta virus.
The following is an excerpt from Dr. Angelique Kotze’s talk on these signs and symptoms:
“The identification of the new strain began with the examination of the patient of a man who was 33 years old. “He told me that he had been feeling very tired for the past few days and had symptoms such as body aches and headaches.”
Dr. Kotze went on to say that the patient did not have a sore throat and instead felt more sore throat, but did not cough or lose his senses of taste and smell, common symptoms of previous strains of the coronavirus.
Dr. Kotze added that the result of the coronary examination of this patient and his family members was positive, and later in the day he saw more patients who had similar symptoms, with symptoms different from those of the corona delta.
It should also be noted that not more than a few days have passed since the outbreak of this new corona strain, and it is a little early to be able to comment definitively on its symptoms.
Why is the spread of the Amicron virus a concern for researchers?
The new Amicron strain has had more than 30 mutations in its spike protein; A binding protein is a key that the virus uses to open and enter cells in the body. This rate of mutation is twice as high as the number of delta mutations.
This sudden change has raised concerns, including that antibodies to previous viral infections or vaccines produced for the corona may not be able to control the new corona strain.
Researchers have predicted that there could be a viral infection or re-infection of those who were immune to other strains of the coronavirus, relying solely on the number of mutations in the amicron-binding protein.
Is the amicron virus more transmissible than other coronavirus mutants?
There is no definitive answer to this question yet, but the picture we have before us is disturbing and daunting.
In just a few days after the discovery of this new strain of the corona virus, the number of cases in South Africa has risen from 273 (the number of cases on November 16) to 1,200. More than 80 percent of these patients are citizens of Khutang, and preliminary research shows that most of these people have Amicron corona.
The R value, which indicates the rate of virus spread, is estimated at 1.47 for South Africa and 1.93 for Khutang province. These figures raise concerns about the start of a new wave of coronavirus outbreaks.
Will current vaccines work against Amicron Corona?
Research into the effectiveness of current vaccines and their role in counteracting the effects of the new strain of coronavirus is ongoing.
Researchers believe that current antibodies and vaccines may not be completely effective in controlling the new Corona strain, but they are likely to provide less immunity than previous mutated viruses.
The main goals and programs that are to be put on the agenda to solve this problem are:
- Production of more vaccines;
- Increase in the number of people receiving the vaccine;
- The third dose of the vaccine is given to those who are most at risk for coronary heart disease.
When we saw the spread of beta, alpha, and delta mutant species, researchers worked tirelessly to improve vaccines and increase their efficacy against these strains, although the vaccines available at the time were largely effective in controlling the destructive effects of these strains. .
The same is true of this new strain of coronavirus, and researchers are updating vaccines and boosting their effectiveness, considering the worst case scenario (the spread of the Amicron and the start of a new wave of the mutated virus). Of course, if a new wave of epidemics is needed and boosted vaccines are needed, it will take at least 4 to 6 months for the vaccines to reach the preparation stage and be available to the public.
What do researchers think about the effectiveness of current drugs in counteracting this new strain?
Antiviral drugs currently used to control and alleviate coronary symptoms, such as Merck’s pill, do not target the virus-binding protein, but prevent the virus from multiplying in the body. Therefore, according to researchers, current antiviral drugs will also be effective in controlling this new strain of coronavirus.
Of course, there are concerns about monoclonal antibodies, such as the anti-coronary drug Regeneron. These antibodies work by targeting parts of the virus that have already mutated, so they may not be effective enough in controlling the symptoms of amicron corona.
Closing remarks; Should we wait for the beginning of a new and more intense wave of the corona epidemic?
If we look at the issue realistically, the situation is not so good. According to reports, this new strain of coronavirus is already affecting many countries around the world. However, researchers still do not have any documented evidence of what the condition will be in the future, and it is unclear whether the new Amicron strain will be more severe and lethal than previous mutant species or if it will have milder symptoms. We have to wait and see what will happen in the future and where the efforts of researchers and global organizations will lead.
If you have a comment on this or you can add information to what has been said, you can share your valuable comments and information with us and the audience of the magazine in the “Post a Comment” section.